Rituximab for treating non-Hodgkin's lymphoma and chronic lymphocytic leukaemia
Agency for Care Effectiveness (ACE)
Record ID 32018002559
English
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/details/rituximab-for-treating-non-hodgkin-s-lymphoma-and-chronic-lymphocytic-leukaemia
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
- Rituximab
- Antineoplastic Agents
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.